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Abstract
Summary Follow-up of a British national survey of older
people found that in men, all-cause mortality was predicted by
baseline plasma concentrations of phosphorus, albumin,
creatinine and α1-antichymotrypsin, and food energy intake
and in women by plasma alkaline phosphatase, creatinine, α1-
antichymotrypsin, 25-hydroxy-vitamin D (marginally), and
phosphorus intake.
Introduction Predictive power, for all-cause mortality, of
bone-related vitamin and mineral indices and intakes, mea-
sured at baseline (primary objective), was studied in the
British National Diet and Nutrition Survey (community-living
subset) of People Aged 65 Years and Over. A secondary
objective was to identify cross-sectional relationships between
indices at baseline to help explain mortality predictions.
Methods Mortality status was recorded for 1,054 (mean age
76.6±7.4 years, 49.0% female) participants from baseline
survey in 1994/1995 until September 2008. Seventy-four
per cent of male and 62% of female participants died. Cox
proportional hazards models were used to relate baseline
nutrient and risk marker estimates to subsequent survival.
Results below 1.0 signified lower risk at greater nutrient
(status or intake) values and vice versa.
Results In both sexes, all-cause mortality was significantly
predicted by body weight and mid-upper arm circumference.
In men, it was predicted by baseline plasma concentrations
(per SD) of: phosphorus (hazard ratio 1.18, 95% confidence
interval (CI)=1.06–1.30), albumin (hazard ratio 0.84, 95% CI
=0.74–0.94), creatinine (hazard ratio 1.20, 95% CI=1.08–
1.33) and α1-antichymotrypsin (hazard ratio 1.21, 95% CI=
1.11–1.33). In women, it was predicted by plasma albumin
(hazard ratio 0.83, 95% CI=0.72–0.96), alkaline phosphatase
(hazard ratio 1.08, 95% CI=1.01–1.16), creatinine (hazard
ratio 1.37, 95% CI=1.13–1.66), α1-antichymotrypsin (hazard
ratio 1.27, 95% CI=1.11–1.45) and marginally by 25-
hydroxy-vitamin D (hazard ratio 0.87, 95% CI=0.75–1.00).
In men, it was predicted by dietary intake (per SD) of food
energy; in women, by intake of phosphorus. Adjustment for
plasma α1-antichymotrypsin or plasma creatinine reduced the
significance of plasma phosphorus in men.
Conclusion Mortality prediction by higher plasma phos-
phorus in older British men may imply impaired renal
function and/or acute phase status. Further studies are
needed on which associations are causal and modifiable.
Keywords British National Survey of Older Adults.
Mortality prediction.Plasma indices and intakes of bone-
related nutrients
Introduction
Relationships between biochemical status indices and risk
of premature mortality can help predict causal relationships
and, thereby, clarify physiological and pathological mech-
anisms that may be related to disease and mortality risk
factors in ageing humans. In a series of studies [1–4], we
have recently focussed on the mortality outcomes of the
subset of community-living participants from the country-
wide British National Diet and Nutrition Survey (NDNS) of
People Aged 65 Years and Over, for which the fieldwork
was performed in 1994–1995 [5]. The primary objective of
the present paper has been to explore the predictive
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nutrient and status indices that are bone-related, plus related
lifestyle and risk indices, nearly all of which were measured
as part of the original (baseline) population surveillance
protocol (a secondary objective was to identify potentially
relevant cross-sectional relationships between indices at
baseline, which might help explain some of the observed
nutrient–mortality relationships).
Certainnutrientstatusindicesareknowntobemodifiedby,
and hence to reflect, acute phase status and/or renal status,
hence, potentially, to reflect mortality risk (since chronic
inflammatory states or impaired kidney function frequently
underlie disease processes that lead ultimately to death) [6].
For instance, several recent studies [7–9]h a v er e p o r t e da n
association between raised serum calcium and/or phosphorus
concentrations and an increased risk of mortality, and have
attributed this association to impaired kidney function or
inflammation as being potentially the cause of both the
abnormal serum mineral levels and the increased risk. For
this reason, we included a biochemical index of acute phase
status (α1-antichymotrypsin) in the study. Since, in a
previous study of mortality predictors in this survey sample,
self-reported physical activity, measured hand grip strength
and smoking habit at baseline were all shown to be
significant predictors of all-cause mortality [3], these three
potential risk modulator indices were also studied, as
possible effect modulators, in the present study. The well-
established links between bone health status and muscular
strength and/or physical activity provided a further justifica-
tion for the inclusion of self-reported physical activity and
measured grip strength in the present study.
A key question, which is pertinent in all of these
mortality risk studies, is whether the observed links
between baseline nutrient status and future mortality are
likely to be driven by (potentially correctable) nutritional
imbalances or by the more intractable and unalterable
processes of ageing and chronic disease.
Subjects and methods
Subjects
The NDNS 65+ years survey procedures have been described
in detail elsewhere [5]; therefore, only a brief summary is
given here. At baseline, in 1994–1995, two separate popula-
tion samples were randomly selected: one from community-
living people aged 65 years and over and the other from long-
stay institutions. Only the community-living sample has been
included. Participants were drawn from 80 randomly selected
postcode sectors in mainland Britain, allocated to four
sequential 3-month fieldwork “waves” corresponding to the
four seasons, beginning in October 1994.
Survey measurements
Demographic, socioeconomic and other information,
including a four-category self-assessment of usual phys-
ical activity plus a three-category self-assessment of
current smoking habit (none, 1–20 cigarettes/day, >20/
day) [5], were obtained by a trained interviewer in the
participant’s home. A 4-day weighed dietary record was
also obtained by the interviewer. Participants were
r e q u e s t e dt ok e e pa 4 - d a yw e i g h e dr e c o r do fa l lf o o d
and drink consumed, which was found to produce
acceptable levels of compliance and completion [5]. They
were issued with a Soehnle Quanta digital food scale to
weigh all food consumed at home, and details of any food
and drink consumed outside were recorded in a separate
diary so that interviewers could purchase duplicate items.
Anthropometric indices were measured by a trained
nurse. Hand grip strength was measured by a hand
dynamometer, designed by the Department of Medical
Physics, Queen’s Medical Centre, Nottingham, UK, using
the mean of four measurements, two on each hand [5].
Physical activity was derived from a lifestyle (including
activity and disability) questionnaire, subsequently sum-
marised in a four-category index, from ‘very active’ to
‘very inactive’ [5]. After separate consent, a fasting early
morning venous blood sample was taken by a trained nurse.
The blood sample was subdivided and used for a wide
range of analyses [5]. Of these, the assays that are relevant
to the present study were: (a) plasma 25-hydroxy vitamin D
(25(OH)D) by a commercial kit assay (Incstar, Minnesota,
USA) based on competitive protein binding to an antibody
to an analogue of 25(OH)D raised in rabbits [5, 10]; (b)
plasma α1-antichymotrypsin and plasma albumin by
antibody-based nephelometric assays (Dako A/S, adapted
for a Roche Cobas Bio autoanalyzer) [5]; (c) plasma
calcium, phosphorus, creatinine and total plasma alkaline
phosphatase by colourimetric assays (Roche clinical assay
kits, for a Roche Cobas autoanalyzer) [5]; the enzyme rate
assay for alkaline phosphatase being based on the hydro-
lysis of p-nitrophenyl phosphate (Roche do.) [5]; and (d)
plasma intact parathyroid hormone (PTH), measured for an
adjunct study by a commercial immunoassay (Nichols-
Allegro, Nichols Diagnostics, San Juan Capistrano, CA,
USA) [11] (plasma calcium, phosphorus, alkaline phospha-
tase, 25(OH)D and parathyroid hormone are all bone-
related indices). Plasma α1-antichymotrypsin was selected
as a medium-duration plasma acute phase indicator, which
tends to remain raised during chronic inflammatory states.
In-house quality assessments and inter-laboratory
exchanges were undertaken in order to monitor the
accuracy and stability of the assays. Between-run quality
control sample coefficients of variation (%) for the principal
plasma index assays were: plasma phosphorus, 2.3;
458 Osteoporos Int (2012) 23:457–466calcium, 2.7; alkaline phosphatase, 2.6; creatinine, 6.0;
albumin, 7.8; antichymotrypsin, 8.0; parathyroid hormone,
8.3; and 25(OH)D, 15.0.
Ethics and approvals
The study was conducted according to the guidelines laid
down in the Declaration of Helsinki, and all procedures
involving human subjects were approved by the Local
Research Ethics Committees representing each of the 80
postcode sectors used. The protocol was also approved by
the Ethical Committee of the MRC Dunn Nutrition Unit (of
which the Micronutrient Status Laboratory is now part of
MRC Human Nutrition Research) in Cambridge. Written
informed consent was obtained from all subjects.
Follow-up mortality study
The present study included 1,054 participants comprising
538 men and 516 women with partial or complete data
available for the analyses of interest here, all of whom
agreed to be flagged on the National Register of Births and
Deaths and whose status (i.e. as still alive or registered as
having died) was known unequivocally in September 2008.
No exclusions, other than those resulting from willingness
to participate or the availability of blood samples, were
imposed, and there was no evidence of sampling bias.
Because of missing values (principally due to incomplete
consent availability for the blood sampling), the analyses of
the blood biomarker variables are typically based on a
subset of 800–900 participants and of 555 for the
parathyroid hormone dataset. Mortality outcomes were
obtained from the National Health and Service (NHS)
register of deaths, up to September 2008.
Statistical analyses
Cox proportional hazards models were used, with years of
survival as the time scale, to estimate the risk of all-cause
mortality. The data were censored to September 2008 in
participants who survived. The proportional hazards
assumption was examined by comparing the cumulative
hazard plots, grouped as exposure; no appreciable viola-
tions were observed. Standardised values (z-scores) were
used for each of the explanatory variables, thus expressing
the hazard ratios per standard deviation rather than per
measurement unit, achieving an enhanced conformity
between indices. Adjustment was made for potential
confounders, including age and sex, in all models.
Multivariable Cox regression model was used to test the
independent effect of nutrient status indices or nutrient
intake estimates after adjustments for acute phase indica-
tors, functional and anthropometric measures. Since rela-
tionships between indices, rather than estimates of
prevalence were of interest, the weighting factors used in
the Survey Report [5] were not used here. All tests of
statistical significance were based on two-sided probability;
P<0.05 was deemed significant.
Results: survey follow-up
Of the community-living survey participants who gave
consent for follow-up flagging of the NHS Register of
deaths and who had provided at least one index value
reported in this follow-up study, 94.5% could be accounted
for by known deaths and known survivors. As noted
previously in “Subjects and methods”, the blood biomarker
analyses are confined to that subset of the participants who
provided a blood sample, generally comprising 800–900
participants.
Baseline characteristics
Table 1 provides mean and median baseline values,
subdivided by sex, for the indices explored in this report.
The Survey Report [5] provided baseline index values for all
of the original survey participants, together with further
details about the selection procedures and the methodologies
used.
Correlations between plasma status indices, and functional
and lifestyle measures
Table 2 shows associations of the plasma status indices with
baseline markers of physical function (hand grip strength
and physical activity) and with current smoking habit. For
men, five of the seven plasma indices were significantly
associated with hand grip strength, but for women, none of
the seven were associated with this index of physical
function. For men, the pattern of associations with a
physical activity score was similar to that for grip strength,
and for women, four of the plasma indices were associated
with the physical activity score. For men, three of the
plasma indices were associated with smoking habit, but for
women, only one (plasma phosphorus) was associated with
this lifestyle index. Plasma PTH was not significantly
correlated with any of the function and lifestyle indices (not
shown).
Hazard ratios for all-cause mortality
Table 3 lists the age- and sex-adjusted hazard ratios for all-
cause mortality for both sexes combined and subdivided by
sex. For the combined sexes, significant predictors of
mortality included plasma 25(OH)D (‘protective’), plasma
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and dietary energy (‘protective’). Dietary calcium was also
‘protective’, but it lost its significance when adjusted for
dietary energy; dietary phosphorus was ‘protective’, but
again lost much of its significance when adjusted for
dietary energy. The following ‘risk indices’ were signifi-
cantly ‘deleterious’: plasma creatinine (kidney function),
plasma alkaline phosphatase (marginally significant: bone
health), plasma α1-antichymotrypsin (acute phase status).
Plasma albumin was significantly ‘protective’, and of the
functional and anthropometric indices shown, grip strength,
body weight and mid-upper arm circumference were
‘protective’, body mass index being only modestly protec-
tive. Notably, plasma calcium was not a significant
predictor, and it remained so after adjustment for plasma
albumin [12] (not shown).
Mortality prediction by 25(OH)D was more signifi-
cant during the winter months (October to March) than
the summer months (April to September). During the
six winter months, the hazard ratio (95% CI) for both
sexes combined was 0.85 (0.74–0.98, P=0.02), whereas
during the six summer months, it was 0.92 (0.82–1.03,
P=0.14). Mortality prediction by 25(OH)D was attenuat-
ed (to P=0.042, 0.045, respectively), but was not
completely abolished by adjustment for either grip
strength or for a physical activity score (on a scale of 1–
4: very active to very inactive, by questionnaire; Table 2).
Mortality prediction by plasma phosphorus was attenuat-
ed (to a P=0.033, 0.041, respectively) by adjustment for
either plasma creatinine or for plasma α1-antichymotryp-
sin (Table 3).
For men (Table 3), significant biochemical and dietary
predictors of all-cause mortality were: plasma phosphorus,
plasma creatinine and plasma α1-antichymotrypsin (all
‘deleterious’), and plasma albumin and dietary intake of
energy (both ‘protective’). For women (Table 3), the
significant predictors were plasma alkaline phosphatase,
creatinine and α1-antichymotrypsin (all ‘deleterious’), 25
(OH)D (marginally ‘protective’), and plasma albumin and
phosphorus intake (‘protective’). If food energy was
included in the model for women, then phosphorus intake
still retained its prediction significance (P=0.01).
Table 1 Summary of selected status indices and nutrient intakes in the survey respondents who are included in the present study (n=1,054)
Men Women
n
a Mean (SD) Median Range n
a Mean (SD) Median Range
Age (years) 538 75.8 (6.9) 75.0 65–96 516 77.3 (7.9) 76.0 65–99
Body weight (kg) 532 75.2 (12.2) 74.6 38.7–121 509 64.0 (12.7) 63.3 32.5–112.9
Height (m) 528 1.69 (0.07) 1.69 1.49–1.98 503 1.55 (0.07) 1.55 1.20–1.75
Body mass index (BMI, kg/m
2) 527 26.3 (3.7) 26.1 16.3–43.2 502 26.6 (4.8) 26.2 14.4–44.6
Waist circumference (cm) 531 97.8 (10.9) 98.0 48–129 511 87.7 (11.7) 86.2 27–131
Mid-upper arm circumference (mm) 537 300 (33) 300 189–409 515 293 (40) 291 176–431
Grip strength (kg) 526 30.0 (11.0) 292 0–98.2 489 17.0 (7.7) 16.2 0–55.6
Biochemical indices
Plasma calcium (mmol/l) 377 2.33 (0.15) 2.32 1.83–2.82 365 2.35 (0.17) 2.33 1.92–2.86
Plasma phosphorus (mmol/l) 376 0.99 (0.17) 0.98 0.56–2.45 365 1.10 (0.17) 1.10 0.61–2.16
Plasma 25-hydroxy-vitamin D (nmol/l) 446 58.4 (27.7) 53.2 5–207 417 49.6 (23.7) 46.3 7–138
Plasma parathyroid hormone (ng/l) 265 31.1 (16.1) 27.0 6–117 290 36.9 (22.8) 31 9–173
Plasma alkaline phosphatase (IU/l) 433 87.9 (35.6) 81.1 34–433 398 98.4 (95.6) 88.1 42–1369
Plasma creatinine (μmol/l) 433 94.5 (41.5) 94.0 0–611 399 82.7 (24.4) 80.5 0–192
Plasma albumin (g/l) 430 42.9 (6.0) 42.8 22.1–63.7 407 42.7 (5.6) 42.5 26.1–66.0
Plasma α1-antichymotrypsin (g/l) 430 0.38 (0.094) 0.365 0.16–1.14 408 0.39 (0.089) 0.385 0.22–1.01
Estimated average daily dietary intakes
Energy (MJ) 538 7.95 (1.94) 7.95 3.44–17.3 516 5.95 (1.42) 5.88 1.91–9.77
Calcium (mg) 538 832 (289) 817 237–2,398 516 697 (255) 659 189–2,081
Phosphorus (mg) 538 1,224 (340) 1,195 325–2,695 516 973 (271) 964 262–2075
Vitamin D (μg) 538 4.46 (3.57) 3.46 0.1–29.8 516 3.41 (2.79) 2.52 0.1–21.1
aThe values for n in this table and the maximum values for n in the following tables are limited to the numbers definitely known to have died or to have
been still alive at the time of the follow-up analysis, i.e. they excluded those (approx. 5% of the original participants) who were lost to follow-up. Where
individual index values of n are lower than the maximum in each table, it was because of missing values since not all of the respondents provided blood (or
sufficient blood) for every one of the assays [1]
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About 19% of the study respondents were regularly
taking over-the-counter dietary supplements which
contained vitamin and/or mineral components, at base-
line, and of these, three quarters (i.e. 14% overall) were
taking vitamin D supplements, but only 5% (i.e. 0.5%
overall) were taking over-the-counter supplements that
contained calcium and/or phosphorus. The mortality
prediction patterns were similar in the (86%) non-
vitamin D supplement users, as in the entire cohort,
with the exception of plasma 25(OH)D and of dietary
phosphorus adjusted for dieta r ye n e r g yi nw o m e n ,b o t h
of which lost significance (P>0.05) when the vitamin D-
containing supplement users were excluded (not shown).
Exclusion of those respondents (approx. 14%) who
died <2 years after the baseline fieldwork made little
difference to any of the index predictions of mortality,
again with the exception of plasma 25(OH)D and of
dietary phosphorus adjusted for dietary energy in
women, both of which lost significance (P>0.05, not
shown).
Only approximately 3% of the participants were taking
any drugs for the treatment of musculoskeletal disorders at
baseline, and exclusion of these made essentially no
difference to the mortality prediction patterns or signifi-
cances (not shown).
Primary vascular disease mortality
When the dataset was reanalysed, with primary vascular
disease mortality as the outcome (i.e. International Classi-
fication of Diseases version 9: 390-359 or version 10: I01-
I99), then only the following three indices were significant
predictors of mortality at P<0.01: grip strength, plasma
creatinine and antichymotrypsin. Plasma albumin, diet
energy and diet phosphorus were marginally significant,
with P values between 0.03 and 0.06.
Multivariable models
In the multivariable Cox regression models, for com-
bined sexes, mid-upper arm circumference, grip strength,
plasma creatinine, albumin and α1-antichymotrypsin
were all significantly (P<0.05) associated with all-cause
mortality (results not shown). For men, the significant
predictors were grip strength, plasma creatinine and α1-
antichymotrypsin, and for women, they were mid-upper
Table 2 Linear regression of plasma bone-related indices versus selected functional and lifestyle indices
Versus hand grip strength
a,b Versus physical activity score
a,c Versus smoking habit
a,d
t value Pt value Pt value P
Plasma indices: men
P-calcium −0.4 0.7 +1.2 0.2 −1.1 0.3
P-phosphorus −2.2 0.03 +2.4 0.015 −0.2 0.9
P-25(OH)D +3.5 0.0005 −3.3 0.001 −2.4 0.02
P-alkaline phosphatase −2.1 0.04 +1.4 0.15 +3.7 0.0003
P-albumin +2.7 0.007 −1.9 0.05 −1.1 0.3
P-creatinine −0.7 0.5 +2.0 0.04 +0.3 0.7
P-α1-antichymotrypsin −2.8 0.005 +3.0 0.003 +4.4 <0.0001
Plasma indices: women
P-calcium −0.8 0.5 −0.8 0.4 +0.5 0.6
P-phosphorus −0.9 0.4 −0.8 0.4 +2.5 0.01
P-25(OH)D +1.6 0.12 −4.1 <0.0001 −1.8 0.08
P-alkaline phosphatase −0.4 0.7 +2.3 0.02 +1.3 0.2
P-albumin +0.2 0.8 −4.2 <0.0001 +0.9 0.4
P-creatinine −0.5 0.6 −0.3 0.7 +0.1 0.9
P-α1-antichymotrypsin −1.5 0.12 +2.3 0.02 +1.6 0.1
aRegressions adjusted for age and confined to those subjects for whom mortality data were available. Alkaline phosphatase, creatinine and α1-
antichymotrypsin were log-transformed before the analyses. df=378–435. P plasma
bContinuous variable: mean estimate for both hands. Higher values denote greater hand grip strength [5]
cFour discrete categories: from 1=very active to 4=very inactive [5]
dThree discrete categories: 0 = non-smoker; 1 = <20 cigarettes/day; 3 = >20 cigarettes/day [5]
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antichymotrypsin. None of the nutrient status indices or
nutrient intake estimates survived into the final multivar-
iable models.
Discussion
Background
Because the predictive value of conventional risk factors for
disease and mortality appears to diminish with advancing
age [13], recent attention has focused on the discriminative
ability of novel risk markers in elderly cohorts [14]. The
primary purpose of the present paper was to explore the
predictive significance of a subset of the biochemical status
indices and nutrient intakes that were measured at baseline
as part of the original population surveillance protocol of
the NDNS of People Aged 65 Years and Over, with a
specific focus on bone-related nutrients and related risk
indices, including hand grip strength (proxy for physical,
i.e. muscular, robustness versus frailty) and physical
activity score (proxy for muscular activity, together with
probable sunlight exposure).
Calcium and phosphorus are major components of bone
mineral whose blood concentrations reflect (inter alia) the
adequacy of supply, and of metabolic control, of these
nutrients in relation to bone health. Plasma 25(OH)D is the
preferred index of vitamin D status, which in turn reflects
the adequacy of vitamin D supply and, hence, the supply
adequacy of its derived hormone, calcitriol, which controls
calcium absorption, distribution and delivery. Its adequacy
is further reflected by plasma PTH levels since this
hormone also reacts to, and controls, bone mineral status
and delivery. Plasma alkaline phosphatase activity is
another indicator of bone mineral status (in the NDNS
survey [5], only total alkaline phosphatase activity was
measured, whose activity includes a bone-specific alkaline
Table 3 Age-adjusted hazard ratios for the anthropometric, biochemical and nutritional indices for all-cause mortality, showing both sexes
combined, and each sex separately
Age-adjusted all-cause mortality: hazard ratios (95% CI) [P]
Both sexes combined Men Women
Died (n = 717), alive
(n = 337)
Died (n = 399), alive
(n = 139)
a
Died (n = 318), alive
(n = 198)
a
Indices (per SD)
Body weight 0.84 (0.77–0.93) [<0.001] 0.84 (0.74–0.95) [0.005] 0.85 (0.74–0.97) [0.02]
Body mass index (BMI) 0.90 (0.83–0.98) [0.02] 0.90 (0.79–1.03) [0.1] 0.90 (0.81–1.01) [0.07]
Waist circumference 0.99 (0.99–1.08) [0.9] 0.95 (0.85–1.07) [0.4] 1.04 (0.92–1.17) [0.6]
Mid-upper arm circumference 0.85 (0.77–0.93) [<0.001] 0.86 (0.76–0.99) [0.03] 0.83(0.74–0.95) [0.005]
Grip strength 0.79 (0.71–0.88) [<0.001] 0.72 (0.64–0.82) [<0.001] 0.97 (0.80–1.17) [0.8]
Plasma calcium (mmol/l) 0.96 (0.88–1.05) [0.3] 0.99 (0.88–1.12) [0.9] 0.92 (0.81–1.05) [0.2]
Plasma phosphorus (P) (mmol/l) 1.13 (1.04–1.23) [0.004] 1.18 (1.06–1.30) [<0.001] 1.04 (0.91–1.20) [0.5]
Plasma P adj. plasma creatinine 1.10 (1.01–1.20) [0.03] 1.17 (1.05–1.30) [0.004] –
Plasma P adj. for plasma α1-antichymotrypsin 1.09 (1.00–1.18) [0.04] 1.10 (1.00–1.21) [0.05] –
Plasma 25OHD (nmol/l) 0.89 (0.82–0.98) [0.01] 0.91 (0.82–1.02) [0.1] 0.87 (0.75–1.00) [0.06]
Plasma parathyroid hormone (ng/l) 1.03 (0.93–1.15) [0.5] 1.03 (0.88–1.21) [0.7] 1.05 (0.91–1.21) [0.5]
Plasma alkaline phosphatase(IU/l) 1.08 (1.01–1.15) [0.02] 1.06 (0.89–1.26) [0.5] 1.08 (1.01–1.16) [0.03]
Plasma creatinine (μmol/l) 1.24 (1.13–1.35) [<0.001] 1.20 (1.08–1.33) [<0.001] 1.37 (1.13–1.66) [<0.001]
Plasma albumin (g/l) 0.83 (0.76–0.91) [<0.001] 0.84 (0.74–0.94) [0.004] 0.83 (0.72–0.96) [0.01]
Plasma α1-antichymotrypsin (g/l) 1.22 (1.14–1.32) [<0.001] 1.21 (1.11–1.33) [<0.001] 1.27 (1.11–1.45) [<0.001]
Daily dietary intakes (per SD)
Energy 0.86 (0.79–0.94) [0.001] 0.85 (0.76–0.95) [0.003] 0.90 (0.77–1.05) [0.2]
Calcium 0.88 (0.81–0.95) [0.002] 0.88 (0.79–0.98) [0.02] 0.89 (0.78–1.01) [0.07]
Calcium adjusted for diet energy 0.93 (0.84–1.03) [0.2] 0.96 (0.84–1.10) [0.6]
Phosphorus 0.85 (0.78–0.92) [<0.001] 0.87 (0.78–0.96) [0.005] 0.82 (0.72–0.95) [0.007]
Phosphorus adjusted for diet energy 0.88 (0.78–0.98) [0.02] 0.93 (0.81–1.07) [0.3] 0.79 (0.86–0.95) [0.01]
Vitamin D 0.94 (0.88–1.01) [0.1] 0.90 (0.82–0.99) [0.03] 1.03 (0.91–1.16) [0.6]
aAs explained in the legend of Table 1, these were the study maximum values for n; the actual values for each index were the same as in Table 1
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mineral status indicator). Plasma creatinine levels reflect
kidney function, plasma α1-antichymotrypsin is a medium-
term acute phase indicator (of inflammatory processes), and
plasma albumin is an indicator of general and hepatic
health, especially in older adults. Of the functional and
anthropometric indices reported here, grip strength obvi-
ously reflects functional muscular strength; arm circumfer-
ence is also a proxy for muscle status and muscle wasting.
The other anthropometric indices reported (body weight,
BMI, waist circumference) reflect body fatness and thus
tend to be reduced in frail older people, especially in the
event of chronic illness. Of the nutrient intakes that were
estimated (from weighed food intake records) during the
survey at baseline [5], only the major bone-related nutrient
intakes (calcium, phosphorus and vitamin D) are reported
here. Whereas calcium and phosphorus are derived from the
diet alone, a major source of vitamin D is, of course, the
action of sunlight on vitamin D precursors in the skin.
About 5% of the survey participants were recorded as
taking regular over-the-counter dietary supplements that
contained one or more of these three nutrients.
In a previous recent study [1], we showed that plasma
zinc (amongst other redox-active nutrient status indices)
robustly predicted subsequent all-cause mortality in this
survey cohort. We note here that a considerable proportion
of the body’s zinc content is found in the bone, with
possible implications for bone health and metabolic
activity.
Several recent studies have reported significant predic-
tion of (better) survival by higher blood vitamin D status
indices or vitamin D supplementation [15–26] and/or by
lower serum or plasma PTH levels [15, 26–28]. Three
recent studies [7–9] have reported poorer survival at higher
levels of serum calcium and/or phosphorus, usually
attributed to impaired kidney function and/or inflammatory
processes, and one of these [8] has also reported an
association between mortality and raised serum alkaline
phosphatase.
Strengths and limitations of study
Important strengths of the present study were that, as far as
possible, the population sample was chosen as being
statistically representative of the community-living people
of mainland Britain in 1994–1995. A wide range of
nutrition-related factors were measured at baseline, includ-
ing questionnaire-derived socio-demographic information, a
4-day weighed diet estimate, anthropometric measurements,
haematology, blood and urine biochemistry (including a
large number of nutritional indices), dental assessment [29],
etc.; the follow-up period for mortality outcomes was
substantial, i.e. 13–14 years.
On the other hand, the survey was originally designed
primarily to characterise food choices and nutritional status
rather than having specific focus on bone health or
subsequent mortality outcomes. Another inevitable weak-
ness, associated inevitably with any cross-sectional national
survey, is the fact that the baseline measures were sampled
at a single time point only. It is thus, in principle, unable to
address issues of long-term causal pathways or of inter-
vening events occurring after the baseline measures. Also,
cost considerations and the primary purposes of the original
survey limited some of the measurements; thus, for
instance, plasma PTH concentrations were measured on a
subset only and other potentially relevant indices, such as
bone-specific alkaline phosphatase, other bone turnover
markers, bone density, etc. were not measured. Although
some information was available to us about cause(s) of
death, there were too few subjects for whom the primary
cause of death was attributed to a musculoskeletal category,
in the International Classification of Diseases attributions,
to permit a meaningful investigation of mortality by cause
of death; therefore, we have focussed primarily on
predictors of all-cause mortality.
It is well known that variable misreporting of dietary
intakes is a major unresolved problem for the interpre-
tation of all surveys that include the estimation of
nutrient intakes. Our survey sought to minimise this
problem by the use of robust 4-day diet estimates based
on weighed food intakes; however, it is clear from data
in the published report [5]( S e c t i o n5 . 2 . 2a n dT a b l e5 . 6
(a)) that 41% of the surveyed men and 59% of the women
had estimated energy intakes below their calculated basal
metabolic rates, suggesting frequent underreporting and/or
misreporting of usual intakes. Nevertheless, any measure-
ment error that is attributable to such misreporting would
clearly result in the attenuation of the observed relation-
ships rather than the strengthening of relationships. We
nevertheless acknowledge that some uncertainty remains
in this respect.
Discussion and interpretation of mortality and inter-index
observations
Biochemical indices
The observation that plasma albumin concentration was a
robust predictor of all-cause mortality in both sexes, higher
concentrations being associated with lower risk (qv Ta-
ble 3), concurs with the traditional viewpoint that plasma
albumin has a positive surrogacy for relatively good
(physiological) health status in older people. Table 2 shows
that plasma albumin was also significantly associated with
hand grip strength in men and with physical activity score
in women.
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mortality in this study even after adjustment for plasma
albumin concentrations [12]. Likewise, plasma calcium was
not significantly associated with hand grip strength,
physical activity score or smoking habit in either sex at
baseline (Table 2).
25(OH)D was significantly related to hand grip strength
in men, to physical activity score in both sexes and to
smoking habit in men (Table 2). However, it was only a
modest predictor of mortality, higher levels being ‘protec-
tive’ as previously reported [15–25], and its significance
was readily lost when health- and lifestyle-related adjusters
(sunlight exposure, hand grip strength and physical activity)
were introduced; it thus appeared to be relatively weak as a
mortality predictor in this population where, for instance,
plasma 25(OH)D concentrations tend to be generally lower
than those observed in the USA. Nevertheless, it is likely
that good bone health promotes better physical function and
independent living in the elderly; thus, we would have
expected the introduction of variables such as physical
activity and hand grip strength into the model to attenuate
the associations. As expected, the power of its prediction
was somewhat greater when the measurement was made in
the winter season than when it was made during the
summer months, suggesting that the winter nadir [5] may
be a more relevant predictive index than the summer
maximum. Plasma PTH exhibited no significant predictive
power in the present study, possibly because relatively few
measurements were available for this index.
Plasma phosphorus was significantly correlated with
hand grip strength and with physical activity score in men,
but only with smoking habit in women. In men, it was also
a robust predictor of mortality, being ‘deleterious’, i.e.
higher levels predicting greater risk. As noted above, an
association between relatively high serum phosphorus
levels and increased morbidity or mortality has been
reported previously in other populations [7–9]a n di s
frequently attributed to an association between raised serum
phosphorus and either impaired kidney function (due, for
instance, to vascular calcification) or chronic inflammatory
processes in older people. Adjustment for either plasma
creatinine (kidney function index) or for plasma α1-
antichymotrypsin (inflammation index) did indeed reduce
the significance of the plasma phosphorus prediction. It is
intriguing, but difficult to explain, that in the present study,
the predictive power of plasma phosphorus was confined to
the men, being essentially absent from the women (Tables 2
and 4).
Another intriguing, but unexplained, sex difference was
that mortality prediction from grip strength was essentially
confined to the male subjects (Table 3) and, moreover, that
hand grip strength was correlated with several of the plasma
status indices in the men, but not in the women (Table 2).
Possibly, men who retain robust grip strength into old age
are generally healthier than those who do not, whereas grip
strength may be less predictive of good health in older
women. Although previous studies on this are not conclu-
sive [30], there appears to be some evidence for stronger
mortality prediction by grip strength in older men than
older women [31, 32].
Dietary and supplemental intakes
As noted previously [2–4], dietary energy intake (especially
when converted to a z-score) was a significant predictor of
mortality in men, higher intakes being associated with
lower mortality risk. This might be explained by lower
mortality risk in those with relatively better appetites and
higher energy expenditures (see above). Dietary calcium
intakes added little or nothing to the mortality prediction by
energy intakes; however, dietary phosphorus intakes were
predictive in women only and were not greatly attenuated
by the addition of dietary energy to the model. The higher
observed food energy and nutrient intakes in men than
women here may be attributable primarily to sex differ-
ences in lean body mass and also, perhaps, to some
differences in energy expenditure.
Vitamin D intake was not a significant predictor in
either sex. Intakes of this vitamin are considerably
below the reference or recommended intakes for the
majority of this age group, 10 μg/day being the
recommendation for people aged 65 years and over in
the UK [33–35]a n d1 5μg/day for people aged 70 years
a n do v e ri nt h eU S A[ 36, 37]; yet, <5% of these British
community-living survey participants had (estimated)
vitamin D intakes of 10 μg/day or above [5].
Use of over-the-counter dietary supplements appeared
not to be a major driver of the association between the
nutrients studied (by status or intake) and mortality
prediction, except possibly in the case of 25(OH)D. One
possible reason why the observed ranges of intakes and
status indices were very wide may be that only a subset
of the survey respondents was regularly using dietary
(nutrient) supplements [5]. A wide range of parathyroid
hormone concentrations may imply the existence of
secondary hyperparathyroidism in some of the subjects
[11].
There was some evidence that the (modest) predictive
power of 25(OH)D could be attenuated by deletion of
those subjects who died within 2 years of the baseline
survey, suggesting that it may be disproportionately
driven by subjects with a preexisting morbidity. There
were too few respondents who were taking prescribed
drugs for treatment of musculoskeletal conditions at
baseline, and too little information available about
chronic medical conditions at baseline, for it to be
464 Osteoporos Int (2012) 23:457–466possible to include these potential factors meaningfully
in the prediction models used in the present study.
Anthropometry
With regard to the anthropometric indices that were
included in the present study, it is noteworthy that in both
sexes, both body weight and mid-upper arm circumference
were robust predictors of mortality, higher values of both
predicting lower risk. Body weight was the stronger
predictor in men, whereas arm circumference was a
stronger predictor in women. Body mass index, in both
sexes, provided little prediction and waist circumference (as
an index of fatness) offered essentially none. However,
reduced body weight did predict shorter survival in both
sexes rather than the opposite prediction, as is generally
observed in younger adults. The fact that none of the
selected nutrient status indices or nutrient intake estimates
survived into multivariable models seems consistent with
the view that these nutrient predictors of mortality may
reflect physiological or pathological processes, such as
renal function or acute phase status.
Conclusion
A number of baseline (survey) indices having known
associations with bone health significantly predicted sub-
sequent all-cause mortality (i.e. survival duration) in older
British adults. Some of the status indices (especially plasma
phosphorus in men) may reflect acute phase status or
impaired kidney function; others (including dietary intakes
of certain nutrients) may reflect the robustness of appetites
and of dentition [29] and the ‘healthiness’ of lifestyles [1–
4]. Future studies should attempt to determine, firstly,
which indices are the most frequent and robust predictors of
all-cause and specific-cause mortality in different popula-
tions and, secondly, whether these predictions can imply
causal relationships such that dietary or other interventions
might promote disease-free longevity.
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